{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:38:23Z","timestamp":1787312303489,"version":"build-2736575974"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100008604","name":"Scleroderma Raynaud\u2019s UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008604","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bath Institute for Rheumatic Diseases"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Cardiovascular disease is a leading cause of mortality in systemic sclerosis (SSc). We investigated the association between SSc and the occurrence of both cardiovascular and thromboembolic events using the Clinical Practice Research Datalink (CPRD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A validated case-ascertainment strategy identified SSc patients in the CPRD. A cohort study design examined rates of coronary arterial disease (CAD), cerebrovascular disease, peripheral artery disease (PAD) and venous thromboembolism (VTE) in SSc patients matched to non-SSc comparators by age, sex and location in a 1:6 ratio. Prevalent and incident cases of SSc were analysed separately. Cox regression analysis was used to determine hazard ratios for event occurrence, adjusted for traditional cardiovascular risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 877 eligible incident cases of SSc who were matched to 5262 patients without SSc (83.7% female), with a mean follow-up of 8\u2009years. We identified a higher background prevalence of CAD, PAD and VTE at baseline (pre-dating diagnosis) in the SSc cohort. There was a significantly increased risk of CAD, PAD, peripheral venous thromboses and pulmonary embolism during follow-up in SSc compared with the non-SSc group (adjusted hazard ratios between 1.84\u20133.01), particularly amongst males. There was no increased risk of cerebrovascular disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We have identified an increased risk of cardiovascular events and VTE, both prior to a diagnosis of SSc and within 8\u2009years of SSc diagnosis. Work is needed to establish the mechanism of arterial\/venous thrombotic events in SSc. This insight will facilitate more targeted and effective preventative strategies and improve outcomes in SSc.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf285","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T07:44:56Z","timestamp":1748591096000},"page":"5330-5337","source":"Crossref","is-referenced-by-count":1,"title":["Cardiovascular and venous thromboembolic events in systemic sclerosis: epidemiological analysis of the Clinical Practice Research Datalink"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2793-2364","authenticated-orcid":false,"given":"John D","family":"Pauling","sequence":"first","affiliation":[{"name":"Department of Rheumatology, North Bristol NHS Trust , Bristol,","place":["UK"]},{"name":"Department of Life Sciences, University of Bath , Bath,","place":["UK"]},{"name":"Translational Health Sciences, Bristol Medical School, University of Bristol , Bristol,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Charlton","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Bath , Bath,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Melbourne , Melbourne,","place":["Australia"]},{"name":"Department of Rheumatology, St Vincent\u2019s Hospital , Melbourne,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J","family":"McHugh","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Bath , Bath,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"McGrogan","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Bath , Bath,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"2025100315130065700_keaf285-B1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41584-020-0386-4","article-title":"Raynaud phenomenon and digital ulcers in systemic sclerosis","volume":"16","author":"Hughes","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2025100315130065700_keaf285-B2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/rheumatology\/key285","article-title":"Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides","volume":"58","author":"Garen","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2025100315130065700_keaf285-B3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","article-title":"Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies","volume":"51","author":"Elhai","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2025100315130065700_keaf285-B4","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/rheumatology\/kead464","article-title":"The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study","volume":"63","author":"Yen","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2025100315130065700_keaf285-B5","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10067-014-2681-4","article-title":"Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis","volume":"33","author":"Ungprasert","year":"2014","journal-title":"Clin Rheumatol"},{"key":"2025100315130065700_keaf285-B6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrrheum.2010.65","article-title":"The burden and measurement of cardiovascular disease in SSc","volume":"6","author":"Mok","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"2025100315130065700_keaf285-B7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/1756-185X.14002","article-title":"Subclinical atherosclerosis in systemic sclerosis: different risk profiles among patients according to clinical manifestations","volume":"24","author":"Sciarra","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"2025100315130065700_keaf285-B8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13075-014-0435-y","article-title":"A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases","volume":"16","author":"Lee","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2025100315130065700_keaf285-B9","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3899\/jrheum.170268","article-title":"Venous Thromboembolism in Systemic Sclerosis: prevalence, Risk Factors, and Effect on Survival","volume":"45","author":"Johnson","year":"2018","journal-title":"J Rheumatol"},{"key":"2025100315130065700_keaf285-B10","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1038\/s41598-024-57275-9","article-title":"Association between systemic sclerosis and risk of cerebrovascular and cardiovascular disease: a meta-analysis","volume":"14","author":"Chen","year":"2024","journal-title":"Sci Rep"},{"key":"2025100315130065700_keaf285-B11","doi-asserted-by":"crossref","first-page":"102494","DOI":"10.1016\/j.autrev.2020.102494","article-title":"Gender-related differences in systemic sclerosis","volume":"19","author":"Hughes","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2025100315130065700_keaf285-B12","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/rheumatology\/keaa680","article-title":"Epidemiology of systemic sclerosis in the UK: an analysis of the Clinical Practice Research Datalink","volume":"60","author":"Pauling","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025100315130065700_keaf285-B13","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bmj.300.6732.1092","article-title":"The Read clinical classification","volume":"300","author":"Chisholm","year":"1990","journal-title":"BMJ"},{"key":"2025100315130065700_keaf285-B14","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart Disease and Stroke Statistics-2023 Update: a Report From the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"2025100315130065700_keaf285-B15","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2025100315130065700_keaf285-B16","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2025100315130065700_keaf285-B17","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/ar4267","article-title":"Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study","volume":"15","author":"Nordin","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2025100315130065700_keaf285-B18","doi-asserted-by":"crossref","first-page":"e013405","DOI":"10.1161\/JAHA.119.013405","article-title":"Cardiovascular manifestations of systemic sclerosis: a Danish Nationwide Cohort Study","volume":"8","author":"Butt","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2025100315130065700_keaf285-B19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/BOR.0000000000000332","article-title":"Recent advances in the pathogenesis and management of Raynaud's phenomenon and digital ulcers","volume":"28","author":"Herrick","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"2025100315130065700_keaf285-B20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.amjmed.2015.10.037","article-title":"Early cardiovascular disease after the diagnosis of systemic sclerosis","volume":"129","author":"Avina-Zubieta","year":"2016","journal-title":"Am J Med"},{"key":"2025100315130065700_keaf285-B21","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1136\/annrheumdis-2011-201176","article-title":"Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis","volume":"71","author":"Ngian","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2025100315130065700_keaf285-B22","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.amjmed.2013.06.025","article-title":"Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study","volume":"126","author":"Chu","year":"2013","journal-title":"Am J Med"},{"key":"2025100315130065700_keaf285-B23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma) a study of fifty-eight autopsy cases and fifty-eight matched controls","volume":"46","author":"D'Angelo","year":"1969","journal-title":"Am J Med"},{"key":"2025100315130065700_keaf285-B24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0002-8703(78)90297-1","article-title":"Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathologic study of 9 patients with progressive systemic sclerosis","volume":"95","author":"Bulkley","year":"1978","journal-title":"Am Heart J"},{"key":"2025100315130065700_keaf285-B25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.53.3.483","article-title":"Myocardial Lesions of Progressive Systemic Sclerosis. A Cause of Cardiac Dysfunction","volume":"53","author":"Bulkley","year":"1976","journal-title":"Circulation"},{"key":"2025100315130065700_keaf285-B26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/23971983241264090","article-title":"Coronary artery calcification is prevalent in systemic sclerosis and is associated with adverse prognosis","volume":"9","author":"Rossdale","year":"2024","journal-title":"J Scleroderma Relat Disord"},{"key":"2025100315130065700_keaf285-B27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10067-006-0211-8","article-title":"Acute myocardial infarction in systemic sclerosis patients: a case series","volume":"26","author":"Derk","year":"2007","journal-title":"Clin Rheumatol"},{"key":"2025100315130065700_keaf285-B28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK","volume":"400","author":"Conrad","year":"2022","journal-title":"Lancet"},{"key":"2025100315130065700_keaf285-B29","first-page":"S48","article-title":"Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin","volume":"28","author":"Allanore","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2025100315130065700_keaf285-B30","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.mayocp.2019.12.015","article-title":"Cardiovascular risk factors and atherosclerotic cardiovascular events among incident cases of systemic sclerosis: results from a population-based cohort (1980-2016)","volume":"95","author":"Kurmann","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"2025100315130065700_keaf285-B31","doi-asserted-by":"crossref","first-page":"1272557","DOI":"10.3389\/fimmu.2024.1272557","article-title":"Evaluating the risk of ischemic stroke at a young age in patients with autoimmune inflammatory rheumatic diseases: a population-based cohort study in Taiwan","volume":"15","author":"Huang","year":"2024","journal-title":"Front Immunol"},{"key":"2025100315130065700_keaf285-B32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3899\/jrheum.181311","article-title":"Increased risk of ischemic stroke in systemic sclerosis: a national cohort study of US Veterans","volume":"47","author":"Ying","year":"2020","journal-title":"J Rheumatol"},{"key":"2025100315130065700_keaf285-B33","doi-asserted-by":"crossref","first-page":"e70032","DOI":"10.1002\/acr2.70032","article-title":"Cerebrovascular Involvement in Systemic Sclerosis","volume":"7","author":"Cutolo","year":"2025","journal-title":"ACR Open Rheumatol"},{"key":"2025100315130065700_keaf285-B34","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/rheumatology\/keu133","article-title":"Systemic sclerosis increases the risks of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study","volume":"53","author":"Chung","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2025100315130065700_keaf285-B35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/acr.22673","article-title":"Risk of pulmonary embolism and deep venous thrombosis in systemic sclerosis: a general population-based study","volume":"68","author":"Schoenfeld","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025100315130065700_keaf285-B36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00393-024-01481-3","article-title":"Association between systemic sclerosis and venous thromboembolism, pulmonary embolism, and deep vein thrombosis: a meta-analysis","volume":"83","author":"Lee","year":"2024","journal-title":"Z Rheumatol"},{"key":"2025100315130065700_keaf285-B37","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.3389\/fimmu.2018.02457","article-title":"Prevalence and clinical associations of antiphospholipid antibodies in systemic sclerosis: new data from a french cross-sectional study, systematic review, and meta-analysis","volume":"9","author":"Sobanski","year":"2018","journal-title":"Front Immunol"},{"key":"2025100315130065700_keaf285-B38","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.semarthrit.2016.10.004","article-title":"Clinical relevance of antiphospholipid antibodies in systemic sclerosis: a systematic review and meta-analysis","volume":"46","author":"Merashli","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2025100315130065700_keaf285-B39","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1007\/s10067-020-05399-4","article-title":"Anti-phospholipid syndrome leading to digital ischaemia and rare organ complications in systemic sclerosis and related disorders","volume":"40","author":"Chatterjee","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2025100315130065700_keaf285-B40","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/art.24684","article-title":"Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients","volume":"60","author":"Boin","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2025100315130065700_keaf285-B41","first-page":"141","article-title":"Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis","volume":"158","author":"Marie","year":"2008","journal-title":"Br J Dermatol"},{"key":"2025100315130065700_keaf285-B42","first-page":"S133","article-title":"The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis","volume":"6","author":"Morrisroe","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2025100315130065700_keaf285-B43","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/annrheumdis-2012-202007","article-title":"The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study","volume":"72","author":"Man","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2025100315130065700_keaf285-B44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41569-022-00797-4","article-title":"Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes","volume":"20","author":"Regitz-Zagrosek","year":"2023","journal-title":"Nature reviews Cardiology"},{"key":"2025100315130065700_keaf285-B45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pcad.2021.12.001","article-title":"The importance of healthy lifestyle behaviors in the prevention of cardiovascular disease","volume":"70","author":"Kaminsky","year":"2022","journal-title":"Prog Cardiovasc Dis"},{"key":"2025100315130065700_keaf285-B46","doi-asserted-by":"crossref","first-page":"152137","DOI":"10.1016\/j.semarthrit.2022.152137","article-title":"Disease specific determinants of cardiopulmonary fitness in systemic sclerosis","volume":"58","author":"Ross","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"2025100315130065700_keaf285-B47","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/09537104.2012.719090","article-title":"The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis","volume":"24","author":"Pauling","year":"2013","journal-title":"Platelets"},{"key":"2025100315130065700_keaf285-B48","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1093\/rheumatology\/keae394","article-title":"The 2024 British Society for Rheumatology guideline for management of systemic sclerosis","volume":"63","author":"Denton","year":"2024","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf285\/63407044\/keaf285.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/10\/5330\/63407044\/keaf285.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/10\/5330\/63407044\/keaf285.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:13:12Z","timestamp":1759518792000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/10\/5330\/8153915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5,30]]},"published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf285","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,5,30]]}}}